The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies

Neurobiology of Disease

Volumn 25, Issue 3, 2007, Pages 665-674

  Dehmel, Thomas ^a   Janke, Angela ^a   Hartung, Hans Peter ^a   Goebel, Hans Hilmar ^b   Wiendl, Heinz ^c   Kieseier, Bernd C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Autoimmune disease; Immunology; Macrophages; Matrix metalloproteinases; Myositis; T lymphocytes

Indexed keywords

ADAM PROTEIN; DISINTEGRIN; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; PROTEIN ADAM10; PROTEIN ADAM12; PROTEIN ADAM17; PROTEIN ADAM19; PROTEIN ADAM8; RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL INCLUSION; CELL POPULATION; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IN VITRO STUDY; INCUBATION TIME; MACROPHAGE; MALE; MUSCLE BIOPSY; MYOBLAST; MYOSITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; T LYMPHOCYTE; UPREGULATION;

ADAM PROTEINS; ADULT; AGED; BIOPSY; CELLS, CULTURED; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MUSCLE FIBERS; MYOBLASTS, SKELETAL; MYOSITIS;

EID: 33847202635     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.11.008     Document Type: Article

References (36)

1. Abel S., Hundhausen C., Mentlein R., Schulte A., Berkhout T.A., Broadway N., Hartmann D., Sedlacek R., Dietrich S., Muetze B., Schuster B., Kallen K.J., Saftig P., Rose-John S., and Ludwig A. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172 (2004) 6362-6372
2. Amour A., Knight C.G., English W.R., Webster A., Slocombe P.M., Knauper V., Docherty A.J., Becherer J.D., Blobel C.P., and Murphy G. The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. FEBS Lett. 524 (2002) 154-158
3. Bridges L.C., and Bowditch R.D. ADAM-integrin interactions: potential integrin regulated ectodomain shedding activity. Curr. Pharm. Des. 11 (2005) 837-847
4. Brou C., Logeat F., Gupta N., Bessia C., LeBail O., Doedens J.R., Cumano A., Roux P., Black R.A., and Israel A. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5 (2000) 207-216
5. Chen X., Raab G., Deutsch U., Zhang J., Ezzell R.M., and Klagsbrun M. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface. J. Biol. Chem. 270 (1995) 18285-18294
6. Choi Y.C., and Dalakas M.C. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 54 (2000) 65-71
7. Cui X., Rouhani F.N., Hawari F., and Levine S.J. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J. Immunol. 171 (2003) 6814-6819
8. Dalakas M.C. Polymyositis, dermatomyositis and inclusion-body myositis. N. Engl. J. Med. 325 (1991) 1487-1498
9. Dalakas M.C. From canine to man: on antibodies, macrophages, and dendritic cells in inflammatory myopathies. Muscle Nerve 29 (2004) 753-755
10. Dalakas M.C., and Hohlfeld R. Polymyositis and dermatomyositis. Lancet 362 (2003) 971-982
11. Engel A.G., Hohlfeld R., and Banker B.Q. The polymyositis and dermatomyositis syndromes. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology (1994), McGraw-Hill, New York 1335-1383
12. Fritsche J., Muller A., Hausmann M., Rogler G., Andreesen R., and Kreutz M. Inverse regulation of the ADAM-family members, decysin and MADDAM/ADAM19 during monocyte differentiation. Immunology 110 (2003) 450-457
13. Goddard D.R., Bunning R.A., and Woodroofe M.N. Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia 34 (2001) 267-271
14. Griggs R.C., Askanas V., DiMauro S., Engel A., Karpati G., Mendell J.R., and Rowland L.P. Inclusion body myositis and myopathies. Ann. Neurol. 38 (1995) 705-713
15. Hurtado O., Lizasoain I., Fernandez-Tome P., Alvarez-Barrientos A., Leza J.C., Lorenzo P., and Moro M.A. TACE/ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate. J. Cereb. Blood Flow Metab. 22 (2002) 576-585
16. Kelly K., Hutchinson G., Nebenius-Oosthuizen D., Smith A.J., Bartsch J.W., Horiuchi K., Rittger A., Manova K., Docherty A.J., and Blobel C.P. Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice. Dev. Dyn. 232 (2005) 221-231
17. Kieseier B.C., Schneider C., Clements J.M., Gearing A.J., Gold R., Toyka K.V., and Hartung H.P. Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain 124 (2001) 341-351
18. Kieseier B.C., Pischel H., Neuen-Jacob E., Tourtellotte W.W., and Hartung H.P. ADAM-10 and ADAM-17 in the inflamed human CNS. Glia 42 (2003) 398-405
19. Kuru S., Inukai A., Liang Y., Doyu M., Takano A., and Sobue G. Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol. (Berl.) 99 (2000) 585-588
20. Kuru S., Inukai A., Kato T., Liang Y., Kimura S., and Sobue G. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies. Acta Neuropathol. (Berl.) 105 (2003) 217-224
21. Kurz M., Pischel H., Hartung H.P., and Kieseier B.C. Tumor necrosis factor-alpha converting enzyme is expressed in the inflamed peripheral nervous system. J. Peripher. Nerv. Syst. 10 (2005) 344-348
22. Lafuste P., Sonnet C., Chazaud B., Dreyfus P.A., Gherardi R.K., Wewer U.M., and Authier F.J. ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation. Mol. Biol. Cell 16 (2005) 861-870
23. Namba K., Nishio M., Mori K., Miyamoto N., Tsurudome M., Ito M., Kawano M., Uchida A., and Ito Y. Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. Cell. Immunol. 213 (2001) 104-113
24. Plumb J., Cross A.K., Surr J., Haddock G., Smith T., Bunning R.A., and Woodroofe M.N. ADAM-17 and TIMP3 protein and mRNA expression in spinal cord white matter of rats with acute experimental autoimmune encephalomyelitis. J. Neuroimmunol. 164 (2005) 1-9
25. Plumb J., McQuaid S., Cross A.K., Surr J., Haddock G., Bunning R.A., and Woodroofe M.N. Upregulation of ADAM-17 expression in active lesion in multiple sclerosis. Mult. Scler. 12 (2006) 375-385
26. Primakoff P., and Myles D.G. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 16 (2000) 83-87
27. Rovida E., Paccagnini A., Del Rosso M., Peschon J., and Dello Sbarba P. TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J. Immunol. 166 (2001) 1583-1589
28. Schlondorff J., and Blobel C.P. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J. Cell Sci. 112 (1999) 3603-3617
29. Schoser B.G., Blottner D., and Stuerenburg H.J. Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers. Acta Neurol. Scand. 105 (2002) 309-313
30. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Weiss E.H., Dichgans J., Lochmuller H., Hohlfeld R., Melms A., and Weller M. The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain 126 (2003) 176-185
31. Wiendl H., Mitsdoerffer M., Schneider D., Melms A., Lochmuller H., Hohlfeld R., and Weller M. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies. Brain 126 (2003) 1026-1035
32. Wiendl H., Hohlfeld R., and Kieseier B.C. The immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol. 26 (2005) 373-380
33. Wolf K., Muller R., Borgmann S., Brocker E.B., and Friedl P. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 102 (2003) 3262-3269
34. Yagami-Hiromasa T., Sato T., Kurisaki T., Kamijo K., Nabeshima Y., and Fujisawa-Sehara A. A metalloprotease-disintegrin participating in myoblast fusion. Nature 377 (1995) 652-656
35. Yoshida S., Setoguchi M., Higuchi Y., Akizuki S., and Yamamoto S. Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int. Immunol. 2 (1990) 585-591
36. Zheng Y., Saftig P., Hartmann D., and Blobel C. Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17). J. Biol. Chem. 279 (2004) 42898-42906